MYD88 and diffuse large B-cell lymphoma: Our findings have been mirrored by previous reports of MYD88 mutation being reported in 30-40% of ABC type DLBCL [43], although lower frequencies have been reported by others [43,44]. MYD88 has been selected as an essential mutation in the ABC [45,46].